Simulations Plus, Inc. (NASDAQ:SLP) Shares Acquired by Janus Henderson Group PLC

Janus Henderson Group PLC increased its holdings in Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 7,753.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 542,899 shares of the technology company's stock after buying an additional 535,986 shares during the quarter. Janus Henderson Group PLC owned about 2.70% of Simulations Plus worth $15,141,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Proficio Capital Partners LLC purchased a new stake in shares of Simulations Plus in the fourth quarter worth about $719,000. JPMorgan Chase & Co. boosted its position in Simulations Plus by 106.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 47,365 shares of the technology company's stock worth $1,517,000 after purchasing an additional 24,371 shares in the last quarter. Sei Investments Co. purchased a new stake in Simulations Plus in the 4th quarter worth approximately $330,000. Tributary Capital Management LLC grew its stake in shares of Simulations Plus by 21.7% during the 4th quarter. Tributary Capital Management LLC now owns 396,093 shares of the technology company's stock worth $11,047,000 after purchasing an additional 70,526 shares during the period. Finally, AlphaQuest LLC increased its holdings in shares of Simulations Plus by 502.9% during the 4th quarter. AlphaQuest LLC now owns 2,689 shares of the technology company's stock valued at $75,000 after purchasing an additional 2,243 shares in the last quarter. 78.08% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $33.51, for a total value of $670,200.00. Following the sale, the director now directly owns 3,344,157 shares of the company's stock, valued at $112,062,701.07. The trade was a 0.59% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 19.40% of the company's stock.

Simulations Plus Stock Performance

Shares of NASDAQ:SLP traded up $0.25 during midday trading on Thursday, reaching $31.95. 60,714 shares of the company's stock traded hands, compared to its average volume of 286,330. Simulations Plus, Inc. has a 1 year low of $23.01 and a 1 year high of $50.98. The company has a market cap of $642.55 million, a P/E ratio of 79.88 and a beta of 1.10. The company has a fifty day simple moving average of $29.39 and a two-hundred day simple moving average of $30.33.

Simulations Plus (NASDAQ:SLP - Get Free Report) last posted its quarterly earnings data on Thursday, April 3rd. The technology company reported $0.31 earnings per share for the quarter, topping analysts' consensus estimates of $0.25 by $0.06. The company had revenue of $22.43 million during the quarter, compared to analysts' expectations of $21.93 million. Simulations Plus had a net margin of 10.97% and a return on equity of 6.84%. The firm's revenue for the quarter was up 22.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.20 earnings per share. As a group, research analysts forecast that Simulations Plus, Inc. will post 1.09 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on SLP shares. KeyCorp increased their price target on shares of Simulations Plus from $32.00 to $40.00 and gave the stock an "overweight" rating in a report on Wednesday, April 16th. Wall Street Zen upgraded shares of Simulations Plus from a "sell" rating to a "hold" rating in a research report on Monday, April 28th. Two equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, Simulations Plus has an average rating of "Moderate Buy" and an average price target of $50.00.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.